See more : Gallant Micro. Machining Co., LTD. (6640.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Surgery Partners, Inc. (SGRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Surgery Partners, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Prime Mining Corp. (PRYM.V) Income Statement Analysis – Financial Results
- Japan Process Development Co., Ltd. (9651.T) Income Statement Analysis – Financial Results
- Chemplast Sanmar Limited (CHEMPLASTS.BO) Income Statement Analysis – Financial Results
- Forward Pharma A/S (FWPAY) Income Statement Analysis – Financial Results
- Peloton Minerals Corporation (PMCCF) Income Statement Analysis – Financial Results
Surgery Partners, Inc. (SGRY)
About Surgery Partners, Inc.
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.60M | 260.22M |
| Cost of Revenue | 2.10B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.20M | 669.33M | 254.18M | 169.84M | 159.35M |
| Gross Profit | 647.50M | 574.90M | 491.40M | 379.80M | 423.80M | 410.03M | 327.42M | 324.24M | 290.57M | 149.11M | 114.76M | 100.87M |
| Gross Profit Ratio | 23.60% | 22.64% | 22.08% | 20.42% | 23.14% | 23.15% | 24.41% | 28.31% | 30.27% | 36.97% | 40.32% | 38.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 120.90M | 102.20M | 104.00M | 97.10M | 88.60M | 93.56M | 75.95M | 60.25M | 55.99M | 31.45M | 26.34M | 25.26M |
| Other Expenses | 198.60M | 112.40M | 60.90M | 48.60M | 75.10M | 63.67M | 25.33M | -3.73M | -119.91M | 21.21M | 17.85M | 14.32M |
| Operating Expenses | 319.50M | 214.60M | 164.90M | 145.70M | 163.70M | 157.23M | 156.37M | 123.66M | 111.83M | 52.66M | 44.18M | 39.58M |
| Cost & Expenses | 2.42B | 2.18B | 1.90B | 1.63B | 1.57B | 1.52B | 1.17B | 944.85M | 781.16M | 306.84M | 214.03M | 198.93M |
| Interest Income | 0.00 | 227.00M | 220.90M | 201.80M | 178.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 193.00M | 234.90M | 221.00M | 201.80M | 178.90M | 147.00M | 117.67M | 100.57M | 100.98M | 62.10M | 32.93M | 28.48M |
| Depreciation & Amortization | 118.10M | 149.60M | 137.90M | 134.20M | 116.50M | 67.44M | 51.93M | 39.55M | 34.55M | 15.06M | 11.66M | 11.21M |
| EBITDA | 446.10M | 460.00M | 401.00M | 277.80M | 336.60M | 144.68M | 251.88M | 245.23M | 59.39M | 65.87M | 69.89M | 72.49M |
| EBITDA Ratio | 16.26% | 19.86% | 20.32% | 18.35% | 18.81% | 18.58% | 19.00% | 21.05% | 10.12% | 27.96% | 28.89% | 27.86% |
| Operating Income | 328.00M | 345.20M | 302.20M | 246.60M | 235.90M | 77.84M | 158.23M | 196.48M | 144.75M | 50.81M | 58.23M | 60.45M |
| Operating Income Ratio | 11.96% | 13.59% | 13.58% | 13.26% | 12.88% | 4.39% | 11.80% | 17.15% | 15.08% | 12.60% | 20.46% | 23.23% |
| Total Other Income/Expenses | -193.00M | -234.90M | -221.00M | -201.80M | -181.30M | -147.00M | -75.95M | -104.30M | -220.89M | -62.10M | -32.93M | -29.31M |
| Income Before Tax | 135.00M | 110.30M | 81.20M | -18.80M | 54.60M | -69.17M | 82.29M | 92.18M | -76.14M | -11.29M | 25.30M | 31.97M |
| Income Before Tax Ratio | 4.92% | 4.34% | 3.65% | -1.01% | 2.98% | -3.90% | 6.14% | 8.05% | -7.93% | -2.80% | 8.89% | 12.29% |
| Income Tax Expense | 300.00K | 23.30M | 10.50M | -20.10M | 8.50M | 26.46M | 53.55M | 7.10M | -148.98M | 15.76M | 7.57M | 6.11M |
| Net Income | -11.90M | 87.00M | 70.70M | 1.30M | 46.10M | -205.71M | -52.99M | 9.45M | 1.43M | -65.90M | -9.06M | 1.92M |
| Net Income Ratio | -0.43% | 3.43% | 3.18% | 0.07% | 2.52% | -11.61% | -3.95% | 0.83% | 0.15% | -16.34% | -3.18% | 0.74% |
| EPS | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| EPS Diluted | -0.09 | 0.95 | 0.98 | 0.03 | 0.95 | -4.28 | -1.08 | 0.20 | 0.04 | -1.37 | -0.19 | 0.04 |
| Weighted Avg Shares Out | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 48.69M | 48.02M | 36.07M | 48.16M | 48.16M | 48.16M |
| Weighted Avg Shares Out (Dil) | 125.61M | 91.95M | 72.43M | 48.78M | 48.28M | 48.03M | 49.00M | 48.19M | 37.46M | 48.16M | 48.16M | 48.16M |
Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2023 results before the market opens on Monday, February...
Why Surgery Partners (SGRY) is Poised to Beat Earnings Estimates Again
Surgery Partners (SGRY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sheridan Capital Partners-Backed Oral Surgery Partners Announces $400M Credit Expansion, Multiple Acquisitions, and C-Suite Hires
CHICAGO--(BUSINESS WIRE)--Oral Surgery Partners (“OSP”), an established and rapidly-growing oral surgery management group backed by Sheridan Capital Partners (“SCP”), announced today the closing of a $400+ million credit expansion to build on existing success in partnership with funds managed by...
Surgery Partners feeling no pinch from macroeconomic weakness
Surgery Partners Inc. NASDAQ: SGRY is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. Its integrated delivery model includes surgical facilities and ancillary services comprised of anesthesia services and multi-specialty physician...
Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook
BRENTWOOD, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 8, 2024, as part...
Surgery Partners, Inc. to Present at Upcoming Investor Conference
BRENTWOOD, Tenn., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will...
Surgery Partners, Inc. Announces Proposed Secondary Offering of Common Stock
BRENTWOOD, Tenn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners” or the “Company”) today announced that certain of the Company's stockholders (the “Selling Stockholders”) intend to offer for sale in an underwritten secondary offering (the...
Surgery Partners, Inc. Completes Refinancing Transaction
BRENTWOOD, Tenn., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company, has received...
Surgery Partners, Inc. (SGRY) Q3 2023 Earnings Call Transcript
Surgery Partners, Inc. (SGRY) Q3 2023 Earnings Call Transcript
Compared to Estimates, Surgery Partners (SGRY) Q3 Earnings: A Look at Key Metrics
The headline numbers for Surgery Partners (SGRY) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Source: https://incomestatements.info
Category: Stock Reports